|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+0.14% | -0.05% |
| 20-01-06 | The Medicines Company Announces Board Changes | CI |
| 20-01-06 | The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care | CI |
| Market Cap | 6.79B 6.19B 5.7B 5.18B 9.73B 629B 10.22B 69.36B 27.57B 343B 25.48B 24.94B 1,078B | P/E 2017 |
-2.79x | P/E 2018 | -11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 7.34B 6.69B 6.16B 5.61B 10.52B 680B 11.05B 75B 29.81B 371B 27.55B 26.97B 1,166B | EV / Sales 2017 |
55.1x | EV / Sales 2018 | 319x |
| Free-Float |
92.97% | Yield 2017 * |
-
| Yield 2018 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/6/20 | Issuer sale | Director | 52,223 | 0.0653% | ||
| 1/6/20 | Sarissa Capital Management LP
| Issuer sale | Company | 4,202,000 | 5.2569% | |
| 1/6/20 | Issuer sale | Chief Development Officer | 309,362 | 0.3870% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.14% | - | - | 6.79B | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | +0.30% | -4.27% | +25.01% | +75.64% | 407B | |
| Weighted average by Cap. | +0.30% | -5.18% | +26.02% | +87.88% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 44.79M 40.79M 37.59M 34.19M 64.15M 4.15B 67.42M 457M 182M 2.27B 168M 165M 7.11B | 6.14M 5.59M 5.15M 4.69M 8.79M 568M 9.24M 62.7M 24.92M 310M 23.03M 22.54M 974M |
| Net income | -708M -645M -595M -541M -1.01B -65.6B -1.07B -7.24B -2.88B -35.83B -2.66B -2.6B -112B | -123M -112M -103M -94.02M -176M -11.4B -185M -1.26B -500M -6.23B -462M -452M -19.55B |
| Net Debt | 498M 453M 418M 380M 713M 46.1B 749M 5.09B 2.02B 25.18B 1.87B 1.83B 79.02B | 552M 503M 463M 421M 790M 51.1B 831M 5.64B 2.24B 27.91B 2.07B 2.03B 87.59B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- MDCO Stock
Select your edition
All financial news and data tailored to specific country editions
















